Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 5Astrocytoma 5Gliosarcoma 4Brain Neoplasms 4Oligodendroglioma 2Medulloblastoma 2Glioma 2Ependymoma 2Central Nervous System Neoplasms 2Triple Negative Breast Neoplasms 1Spinal Cord Neoplasms 1Rhabdoid Tumor 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive 1Nervous System Neoplasms 1Neoplasm Metastasis 1Familial ependymoma 1Choroid Plexus Neoplasms 1Central Nervous System Diseases 1Breast Neoplasms 1Brain Diseases 1

Interventions

XENP 1595 2Cancer Vaccines 2Bevacizumab 2Adjuvants, Immunologic 2veliparib 1glutathione pegylated liposomal doxorubicin 1etoposide phosphate 1elacestrant 1binimetinib 1abemaciclib 1Trastuzumab 1Tissue Banks 1Temozolomide 1Radiotherapy 1Radiosurgery 1Radiation 1RAD1901 1Patient Discharge 1PF-07284890 1Midazolam 1Etoposide 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Diseases × veliparib × CNS × Clear all
NCT00649207 2017-11-21

A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases

AbbVie

Phase 1 Completed
80 enrolled
CNS

Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, Neoplasm Metastasis, Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡